Infant mortality in the U.S. fell to an all-time low in 2025 thanks to antibody shots and RSV vaccines

In 2025, the U.S. saw a historic drop in infant mortality, largely attributed to the introduction of antibody shots and RSV vaccines. Despite this progress, the rate remains higher than in other high-income nations, highlighting ongoing disparities in healthcare outcomes. This shift underscores the importance of continued advancements in medical technology and public health policies to bridge these gaps and ensure equitable health benefits for all infants.